TONIX Pharmaceuticals announces Phase 2a study results of cyclobenzaprine in Fibromyalgia Syndrome
Links shared publicly online about this topic.
- 738total visits
TONIX Pharmaceuticals announces Phase 2a study results of cyclobenzaprine in Fibromyalgia Syndrome
TONIX Pharmaceuticals (formerly known as Krele Pharmaceuticals), a specialty central nervous system (CNS) pharmaceutical company, announced today results of a new analysis of a Phase 2a study, which previously demonstrated reduced pain, fatigue and tenderness in patients with Fibromyalgia Syndrome (FMS) following bedtime administration of very low dosage (VLD) cyclobenzaprine (CBP).
View full resource at news-medical.net
Tags: Nervous System, Pain, Fibromyalgia, Disease and Condition, Pharma, Muscle Relaxer, Flexeril
Most Recently Shared on November 10, 2010 at 9:04 am By:
TONIX Pharmaceuticals announces Phase 2a study results of cyclobenzaprine in Fibromyalgia Syndrome: TONIX Pharma... http://bit.ly/b59wO1
TONIX Pharmaceuticals Reports Analysis of Phase 2a Study of Very Low Dosage Cyclobenzaprine in Fibromyalgia Syndrome (FMS) - Drugs.com MedNews
drugs.com — “For the First Time, Correlation Demonstrated between Sleep Stability and Reductions of Fatigue In FMS - Results Presented at the American College of Rheumatolog” View full resource at drugs.com
Most Recently Shared on November 9, 2010 at 3:21 pm By:
Drugs and Devices OW OW Health
TONIX Pharmaceuticals Reports Analysis of Phase 2a Study of Very Low Dosage Cyclobenzaprine in Fibromyalgi... http://bit.ly/bBELqX #drug
Advertisement
